I can take a first crack at that.
I think you've heard some of the barriers we're facing right now from the testimony we've had, specifically on crop input products in terms of the different timing of approvals, and some of the problems we're having on the maximum residue limits. Right now, we're dealing with a patchwork of regulations instead of one common standard that would maybe be available through Codex. That's definitely one of the issues we face as an industry.
The second issue is for canola, and more on the biotech side. About 98% of the canola grown in Canada is from a biotech variety, and we have a market access policy in our industry, which means that without prior approval in our export markets, we will not bring it to commercialization in Canada. We will not see that product available.
It's the same thing on the crop input side. We will not see that product available to producers until we secure the regulatory approvals in our export market.
The time it takes to do that is time that farmers don't have access to that technology. It's time that we don't have for the innovations on farms.
Those would probably be the two largest non-tariff barriers that we would be addressing.